Home

közösség Érvényesítés hinta copd 5 year overall survival mérnök Gondolat részvény

COPD in the general population: Prevalence, incidence and survival -  ScienceDirect
COPD in the general population: Prevalence, incidence and survival - ScienceDirect

Deep radiomics-based survival prediction in patients with chronic  obstructive pulmonary disease | Scientific Reports
Deep radiomics-based survival prediction in patients with chronic obstructive pulmonary disease | Scientific Reports

Potential misclassification of causes of death from COPD | European  Respiratory Society
Potential misclassification of causes of death from COPD | European Respiratory Society

Kaplan-Meier overall survival curves of patients with colon... | Download  Scientific Diagram
Kaplan-Meier overall survival curves of patients with colon... | Download Scientific Diagram

COPD in the general population: Prevalence, incidence and survival -  ScienceDirect
COPD in the general population: Prevalence, incidence and survival - ScienceDirect

Prediction of five-year mortality after COPD diagnosis using primary care  records | PLOS ONE
Prediction of five-year mortality after COPD diagnosis using primary care records | PLOS ONE

Influence of prolonged QTc on overall survival in COPD patients... |  Download Scientific Diagram
Influence of prolonged QTc on overall survival in COPD patients... | Download Scientific Diagram

Cancers | Free Full-Text | Impact of Chronic Obstruction Pulmonary Disease  on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma  Undergoing Concurrent Chemoradiotherapy
Cancers | Free Full-Text | Impact of Chronic Obstruction Pulmonary Disease on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy

Effect of COPD on symptoms, quality of life and prognosis in patients with  advanced non-small cell lung cancer | BMC Cancer | Full Text
Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer | BMC Cancer | Full Text

JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth  Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide,  Population-Based Cohort Study
JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study

Overall survival curve of COPD and non-COPD cohorts (before PS... |  Download Scientific Diagram
Overall survival curve of COPD and non-COPD cohorts (before PS... | Download Scientific Diagram

Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to  optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery

Severe acute exacerbations and mortality in patients with chronic  obstructive pulmonary disease | Thorax
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease | Thorax

Prediction of five-year mortality after COPD diagnosis using primary care  records | PLOS ONE
Prediction of five-year mortality after COPD diagnosis using primary care records | PLOS ONE

Towards the elimination of chronic obstructive pulmonary disease: a Lancet  Commission - The Lancet
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission - The Lancet

Impact of COPD on prognosis of lung cancer: from a perspective on dise |  COPD
Impact of COPD on prognosis of lung cancer: from a perspective on dise | COPD

Management of Chronic Obstructive Pulmonary Disease | NEJM
Management of Chronic Obstructive Pulmonary Disease | NEJM

JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth  Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide,  Population-Based Cohort Study
JCM | Free Full-Text | Presence of Chronic Obstructive Pulmonary Disease ( COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study

COPD and the risk of poor outcomes in COVID-19: A systematic review and  meta-analysis - eClinicalMedicine
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis - eClinicalMedicine

Survival impact of treatment for chronic obstructive pulmonary disease in  patients with advanced non-small-cell lung cancer | Scientific Reports
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer | Scientific Reports

Survival associated with chronic obstructive pulmonary disease among S |  COPD
Survival associated with chronic obstructive pulmonary disease among S | COPD

a) Overall survival probability categorized by Diagnoses in 1996. (b)... |  Download Scientific Diagram
a) Overall survival probability categorized by Diagnoses in 1996. (b)... | Download Scientific Diagram

Survival associated with chronic obstructive pulmonary disease among S |  COPD
Survival associated with chronic obstructive pulmonary disease among S | COPD

Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in  Patients With COPD - ScienceDirect
Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD - ScienceDirect